Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 15Interventional 4

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1Thoracic 1

Conditions

Neoplasms 2Urinary Bladder Neoplasms 1Recurrence 1Prostatic Neoplasms 1Neoplasm Metastasis 1Disease 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Urine Specimen Collection × Clear all
NCT02807129 2026-01-21

AgElOn

CHU de Reims

Phase NA Completed
296 enrolled
Tumor-Agnostic

Neoplasms

NCT06046131 2025-11-17

KP-CARAIBES

Centre Hospitalier Universitaire de la Guadeloupe

Phase NA Recruiting
3,000 enrolled
Genitourinary

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT05151341 2025-07-24

URODX-FGFR3

Institut de Cancérologie de Lorraine

Phase NA Completed
190 enrolled
Genitourinary

Urinary Bladder Neoplasms, Disease, Neoplasms

NCT03998189 2021-11-05

Metabolic and Microbial Profiling of Lung Cancer

Wake Forest University Health Sciences

Phase NA Terminated
1 enrolled 4 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡